Annual physicals are better than nothing, but the standard bloodwork panel ordered by most primary care physicians was designed to detect disease — not to track health trends or identify early dysfunction. The difference between "no disease present" and "optimized for performance and longevity" is a much wider gap than a standard metabolic panel can see.
The biomarkers that give you the most signal change across decades. What's worth testing at 32 is not identical to what's worth testing at 48, and what's essential at 52 requires a different clinical picture entirely. This guide breaks down what to test, when, and what to do with the results.
Principles That Apply Across All Ages
Before getting into decade-specific panels, a few principles:
Trend data is worth exponentially more than snapshots. A single testosterone reading of 520 ng/dL tells you your status today. A series of readings over four years showing 680, 620, 560, 520 tells you your trajectory — which is the actually useful information for intervention.
Optimal ranges are not the same as reference ranges. Reference ranges are derived from population distributions of people who show up for testing — which includes many metabolically unhealthy individuals. Optimal ranges are narrower and oriented toward function and longevity rather than absence of disease.
Test in consistent conditions. Fasting for metabolic markers, morning testing for hormonal markers, same lab for comparability. Variables in testing conditions create noise that makes trend analysis unreliable.
Related: Want to put this into practice? Try our Biological Age Calculator to get started, and check out Hormone Changes by Decade: What to Expect and Track and Men's Health Optimization by Decade for more context.
In Your 30s: Establishing Baselines
The primary goal in your 30s is baseline establishment. You want reference points for your own health — pre-decline measurements that become enormously valuable when you compare them to tests at 45 or 50.
Hormonal Baseline
| Biomarker | When to Test | Optimal Target |
|---|---|---|
| Total testosterone | Morning, fasted | 600–900 ng/dL for men in their 30s |
| Free testosterone | Same draw | 15–25 pg/mL |
| SHBG | Same draw | 20–40 nmol/L |
| Estradiol (E2) | Same draw | 20–30 pg/mL |
| LH | Same draw | 2–8 IU/L |
| TSH | Fasted | 0.5–2.5 mIU/L |
The standard "normal" range for total testosterone (roughly 300–1000 ng/dL) spans a huge range and is not age-adjusted in most clinical labs. A man in his early 30s with testosterone of 340 ng/dL is "normal" by the chart but likely in the bottom 10th percentile for his age. Context matters.
Metabolic Baseline
| Biomarker | Optimal Target | Why It Matters |
|---|---|---|
| Fasting glucose | 70–90 mg/dL | Glucose regulation and insulin sensitivity |
| Fasting insulin | Below 8 uIU/mL | Early insulin resistance detection |
| HOMA-IR (calculated) | Below 1.5 | Composite insulin resistance metric |
| HbA1c | 4.8–5.3% | 3-month glucose trend |
| ApoB | Below 80 mg/dL | Atherogenic particle count — more predictive than LDL |
| Triglycerides | Below 80 mg/dL | Metabolic and cardiovascular health |
| HDL | Above 50 mg/dL | Cardiovascular risk |
Other Baseline Tests
- hsCRP: below 1.0 mg/L (inflammatory status)
- Vitamin D (25-OH): 50–70 ng/mL
- Ferritin: 50–150 ng/mL for men
- Complete blood count and metabolic panel
Frequency in your 30s: Annual comprehensive panel. Every two years for markers that don't change quickly (ferritin, thyroid).
In Your 40s: Active Surveillance
Your 40s are when passive monitoring transitions to active surveillance. Several physiological processes are in motion simultaneously — testosterone declining, insulin sensitivity shifting, cardiovascular risk building — and you want to catch any of these trends early enough to intervene effectively.
The 40s-Specific Additions
PSA (prostate-specific antigen) becomes worth tracking at 40, earlier with family history. The goal isn't to diagnose anything — it's to establish your personal baseline. A PSA that doubles over two years is clinically significant regardless of absolute level.
CAC (coronary artery calcium) score — this is not a blood test but a brief low-dose CT scan. A CAC score of 0 at 45 is highly reassuring. A non-zero score — especially above 100 — changes clinical conversation substantially. This is the test most cardiologists wish more men in their 40s would get.
Free T3 and reverse T3 become worth adding to thyroid panels. TSH alone misses subclinical thyroid dysfunction that can present as fatigue, cognitive fog, and recovery impairment.
Homocysteine — associated with cardiovascular risk and B-vitamin status. Elevated homocysteine is addressable with methylated B vitamins and is worth knowing about.
Pros
- +CAC scoring at 40–45 provides direct cardiovascular risk data no blood test can match
- +PSA baseline in your 40s makes later readings far more interpretable
- +Trend data across your 40s gives you early warning of metabolic drift while it's still highly reversible
- +Free T3 and reverse T3 catch thyroid dysfunction that TSH alone misses
- +Expanding your panel in your 40s is still relatively inexpensive and increasingly covered by insurance
Cons
- -CAC scanning involves low-dose radiation exposure — appropriate once, not annually
- -More biomarkers means more potential false positives and more decisions to make
- -Reference ranges are still population-derived, not personalized — numbers must be interpreted in context
- -Some optimal-range targets are not universally accepted in conventional medicine
Tracking Frequency in Your 40s
- Hormonal panel (testosterone, SHBG, E2, LH): Every 6–12 months if you're managing any symptoms
- Metabolic panel: Annually at minimum; twice yearly if fasting insulin or glucose is trending up
- PSA: Annually from age 40
- CAC scan: Once at 40–45; repeat at 50–55 depending on the score
- Full lipid panel with ApoB: Annually
In Your 50s: Comprehensive Monitoring
Your 50s call for the most thorough biomarker monitoring of any decade. The compounding effects of prior decades are reflected in your data, and the interventions — both lifestyle and clinical — require detailed information to calibrate correctly.
The 50s-Specific Additions
DEXA scan (dual-energy X-ray absorptiometry) measures both bone mineral density and body composition with precision that no scale or visual assessment can match. Bone density decline in men accelerates in the 50s. Lean mass versus fat mass — not just weight — is what determines metabolic health.
ApoE genotype (one-time test) — if you haven't had this done, your 50s is the time. ApoE4 carriers have significantly elevated risk for cardiovascular disease and cognitive decline, which informs supplementation (fish oil dosing, statins), lifestyle priorities, and screening frequency.
IGF-1 — a proxy for growth hormone activity. Declines with age; relevant to muscle preservation, cognitive function, and bone density.
Testosterone panel adds DHT — dihydrotestosterone declines with age and is relevant to libido, cognitive function, and body composition. Men who have been on finasteride should track DHT closely.
The DEXA scan gives you two numbers that matter more than your weight: lean mass and visceral fat area. Visceral fat is metabolically active in ways that subcutaneous fat is not — it converts testosterone to estrogen and drives systemic inflammation. Body weight can be misleading; visceral fat distribution is not.
The 50s Monitoring Schedule
| Test | Frequency | Notes |
|---|---|---|
| Full hormonal panel | Every 6 months | Especially if managing any symptoms |
| Metabolic panel | Twice yearly | Fasting insulin is the key leading indicator |
| PSA | Annually | Discuss with physician if family history or prior elevation |
| DEXA scan | Every 2–3 years | Bone density + body composition |
| CAC (if score was 0 at 45) | At 55 | Repeat only if previously 0 or low |
| Colonoscopy | At 45, then every 10 years (or per physician) | Colorectal cancer screening |
| ApoE genotype | Once | Informs long-term strategy |
How to Use This Data
Biomarker data is only useful if it drives decisions. The three-step cycle:
- Establish baseline — get tested under consistent conditions; record everything
- Intervene with one change at a time — add a supplement, change a training variable, adjust diet
- Re-test the relevant markers after 8–12 weeks and compare
Be the first to try Prova
We're building an app to track whether biomarker tracking actually works. Join the waitlist.
If you're changing multiple things simultaneously, you can't know what moved the needle. If you're testing once a year but changing your protocol every month, the data can't tell you much. Structured experimentation — one change, tracked against relevant data — is how biomarker monitoring becomes actionable.
The Bottom Line
The most useful health data you can collect is your own, tracked over time, under consistent conditions. Annual bloodwork starting in your 30s builds the longitudinal record that makes each subsequent test exponentially more informative.
The biomarkers shift by decade: hormone baselines in your 30s, cardiovascular and metabolic surveillance in your 40s, comprehensive monitoring including bone density and imaging in your 50s. The through-line is the same in every decade — measure consistently, track trends, and use data to drive interventions.